SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Halstead Regulatory News (JHD)

Share Price Information for James Halstead (JHD)

Share Price is delayed by 15 minutes
Get Live Data
128.80    4.60 (3.70%)
Bid:
128.20
Ask:
129.60
Spread: 1.40 (1.092%)
Market Cap: £536.34m
JHD Live PriceLast checked at - London Stock Exchange

Intraday James Halstead Share Chart

Pre Close Trading Statement

29 Jan 2018 07:00

RNS Number : 0995D
James Halstead PLC
29 January 2018
 

 

 

29 January 2018

 

JAMES HALSTEAD PLCPre Close Trading Statement

James Halstead plc, the commercial flooring manufacturer and distributor, is providing the following trading update ahead of its interim results for the half-year to 31 December 2017.

 

Turnover has increased by 5%, boosted by a strong December, and profit is in line with expectations and in excess of the comparative half-year. Having achieved revenue increases in the majority of our key markets, including Germany, the UK and Australasia, this has resulted in a record level of turnover in the half year.In his AGM trading update, on 1 December 2017, Mr. Geoffrey Halstead noted that trading to date had been in line with our budgets albeit against competitive headwinds. In particular, the central European markets (the principal of which is Germany) have been very competitive with very keen pricing. However, in early January a German manufacturer entered administration and announced the closure of its sheet vinyl and tile facility. This closure is expected to take place imminently and this should ameliorate the pricing pressures we have been experiencing.

 

Product development continues and we have refreshed some of our key ranges and presented them to the trade in recent weeks. Given the positive feedback, our confidence for the full year is unchanged and remains positive.

 

 

Enquiries:

 

James Halstead plc

Tel: 016 1767 2500

Mark Halstead, Chief Executive

 

Gordon Oliver, Finance Director

 

 

 

Hudson Sandler

Tel: 020 7796 4133

Nick Lyon

 

 

 

Panmure Gordon (Nomad and Joint Broker)

Tel: 020 7886 2500

Ben Thorne

Andrew Potts

 

 

 

 

Arden Partners (Joint Broker)

Chris Hardie

 

Tel: 020 7614 5900

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTEQLFLVFFBBBE
Date   Source Headline
16th Aug 20073:00 pmRNSAIM Rule 26
25th Jul 20077:00 amRNSPre-close Trading Update
24th Jul 20074:18 pmRNSDirectors' Dealings
29th Jun 200711:02 amRNSTotal Voting Rights
12th Jun 20074:19 pmRNSDirector/PDMR Shareholding
3rd May 200711:33 amRNSTrading Statement
26th Apr 20074:52 pmRNSBlock listing returns
28th Mar 20077:01 amRNSInterim Results
14th Mar 20074:47 pmRNSNotice of Results
21st Dec 20065:43 pmRNSTotal Voting Rights
4th Dec 200612:23 pmRNSDividend Declaration
1st Dec 20067:01 amRNSAGM Statement
15th Nov 20067:30 amRNSSite visit
18th Oct 20067:01 amRNSIssue of Shares
17th Oct 200610:43 amRNSIssue of Shares
22nd Sep 20067:00 amRNSPreliminary Results
12th Sep 200610:47 amRNSNotice of Results
3rd Jul 20068:44 amRNSChange of Adviser
30th Mar 200611:29 amRNSDirector's shareholding
30th Mar 20067:01 amRNSInterim Results
2nd Mar 20067:01 amRNSNotice of Results
27th Feb 20067:00 amRNSShare sub-division
9th Feb 20062:26 pmRNSShare sub-division
11th Jan 20061:06 pmRNSDirector's shareholding
9th Jan 20062:59 pmRNSGrant of options
6th Jan 200612:58 pmRNSExercise of options etc.
2nd Dec 20058:00 amRNSAGM Statement
2nd Nov 20057:00 amRNSExercise of options etc.
14th Oct 20054:18 pmRNSDirector's shareholding
4th Oct 20057:00 amRNSFinal Results
16th Sep 20053:09 pmRNSNotice of Results
14th Sep 20052:57 pmRNSNotice of Results
3rd Aug 20059:21 amRNSBlock listing application
1st Jun 200512:14 pmRNSBlocklisting Interim Review
4th May 20052:32 pmRNSDirector Shareholding
30th Mar 20057:00 amRNSInterim Results
24th Mar 20059:13 amRNSNotice of Results
14th Jan 20057:00 amRNSB Share and C Share Elections

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.